Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5084707
Max Phase: Preclinical
Molecular Formula: C20H20FN5O4
Molecular Weight: 413.41
Molecule Type: Unknown
Associated Items:
ID: ALA5084707
Max Phase: Preclinical
Molecular Formula: C20H20FN5O4
Molecular Weight: 413.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(N2C(=O)c3cc([N+](=O)[O-])ccc3N=C3C2N(C)CCN3C)cc1F
Standard InChI: InChI=1S/C20H20FN5O4/c1-23-8-9-24(2)19-18(23)22-16-6-4-13(26(28)29)10-14(16)20(27)25(19)12-5-7-17(30-3)15(21)11-12/h4-7,10-11,19H,8-9H2,1-3H3
Standard InChI Key: ITIBMENSRFHFIY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.41 | Molecular Weight (Monoisotopic): 413.1499 | AlogP: 2.64 | #Rotatable Bonds: 3 |
Polar Surface Area: 91.52 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.96 | CX LogP: 2.46 | CX LogD: 2.46 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.57 | Np Likeness Score: -1.05 |
1. Ryan MC, Kim E, Cao X, Reichard W, Ogorek TJ, Das P, Jonsson CB, Baudry J, Chung D, Golden JE.. (2022) Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones., 13 (4.0): [PMID:35450382] [10.1021/acsmedchemlett.1c00539] |
Source(1):